Dr. Sher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
802 W Park Ave
Suite 213
Ocean, NJ 07712Phone+1 732-695-2555Fax+1 732-695-2552
Education & Training
- University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1990 - 1992
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1990
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1986 - 1989
- Georgetown University School of MedicineClass of 1986
Certifications & Licensure
- NJ State Medical License 1993 - 2025
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2022
- New Jersey Life: Top Doctors Castle Connolly, 2005-2022
- New Jersey Monthly: Top Doctors 2003, 2005-2022
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsIntranasal corticosteroids: the role of patient preference and satisfaction.Ellen R. Sher, Jacqueline A. Ross
Allergy and Asthma Proceedings. 2014-01-01 - 4 citationsLebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.Jonathan Corren, Stanley J Szefler, Ellen Sher, Phillip Korenblat, Weily Soong
The Journal of Allergy and Clinical Immunology. in Practice. 2024-05-01 - 4 citationsCurrent and emerging therapies for eosinophilic esophagitis.Ellen R Sher, Jacqueline A Ross, Douglas M Weine, Arundhati Chandini Arjun
Allergy and Asthma Proceedings. 2022-05-01
Press Mentions
- Glimpses of Hope for Lebrikizumab in AsthmaFebruary 28th, 2022
- AR101 Demonstrates Consistent Efficacy and Safety in New Analysis at ACAAI Comparing PALISADE and ARTEMIS Phase 3 Clinical DataNovember 8th, 2019
- AR101 Benefits Pediatric Food Allergy Across Varied SeverityNovember 8th, 2019
- Join now to see all
Committees
- Chair Allergic Skin Disease Committee, American Academy of Allergy & Immunology 2021 - Present
- Member and Programming committee, Eosinophilic Esophagitis Committee American Academy of Allergy & Immunology 2013 - Present
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: